Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor
ClinicalTrials.gov study NCT01068769. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma .
ClinicalTrials.gov study NCT02788006. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01774344. IPD Sharing: UNDECIDED. Countries: 21. Publications: 4.
Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy
ClinicalTrials.gov study NCT01103323. IPD Sharing: Not stated. Countries: 19. Publications: 4.
Phase II Study of Perindopril and Regorafenib in mCRC
ClinicalTrials.gov study NCT02651415. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients
ClinicalTrials.gov study NCT03829462. IPD Sharing: YES. Countries: 1. Publications: 4.
Targeting cell-matrix induced chemoresistance with regorafenib in a 3D model of osteosarcoma
Open the record for dataset details and reuse information.
Follow-up representative source data of metastatic colorectal cancer patients treated with TAS-102 and regorafenib
<p>Follow-up representative source data of metastatic colorectal cancer patients treated with TAS-102 and regorafenib (date of vital status and tomographic scans).</p>
Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05573282. IPD Sharing: NO. Countries: 1. Publications: 3.
Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy
ClinicalTrials.gov study NCT02307500. IPD Sharing: Not stated. Countries: 1. Publications: 29.
Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation
ClinicalTrials.gov study NCT02606097. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05963490. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients
ClinicalTrials.gov study NCT03829852. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04362839. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib
ClinicalTrials.gov study NCT02699073. IPD Sharing: NO. Countries: 1. Publications: 2.
Regorafenib Versus Placebo to Treat Cholangiocarcinoma
ClinicalTrials.gov study NCT02162914. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT02386397. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
ClinicalTrials.gov study NCT02365441. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Regorafenib Post-marketing Surveillance in Japan
ClinicalTrials.gov study NCT01933958. IPD Sharing: NO. Countries: 1. Publications: 2.
Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04534218. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.